Diagnostic Value of a Novel Eosinophil Cationic Protein-Myeloperoxidase Test Paper Before and After Treatment for Allergic Rhinitis
Open Access
- 4 August 2022
- journal article
- research article
- Published by Taylor & Francis in Journal of Asthma and Allergy
- Vol. ume 15, 1005-1019
Abstract
Purpose: To develop and evaluate the effectiveness/clinical application of an eosinophil cationic protein-myeloperoxidase (ECP-MPO) test paper before and after treatment in patients with allergic rhinitis (AR). Patients and Methods: We included 40 controls and 106 AR patients who were enrolled in the Allergy Clinic of Renmin Hospital of Wuhan University. Total IgE, specific IgE and skin prick test (SPT) were detected in all participants. AR patients were treated with oral cetirizine hydrochloride for 14 days. The ECP-MPO test paper results, nasal secretion smear and eosinophil counts, rhinoconjunctivitis total nasal symptom score (TNSS), quality of life questionnaire (RQLQ), visual analogue scale (VAS), serum Th1/Th2/Th17 cytokine, and chemokine data were collected pre- and post-treatment. ECP concentrations in nasal secretions were assessed by ELISA. Pearson correlation test and Kappa consistency test were used for statistical analysis. Results: The post-treatment colour grade of the ECP-MPO test paper was lower in AR patients than the pre-treatment grade. The chromogenic grade correlated positively with the ECP concentration and the eosinophil count in nasal secretions both before and after treatment. Positive ECP-MPO test paper results were consistent with positive SPT, Der p-IgE and Der f-IgE result (Kappa values, 0.843, 0.810, 0.795, respectively). The pre- and post-treatment chromogenic grades correlated positively with the TNSS (r1=0· 691; r2=0· 539), RQLQ (r1=0· 783; r2=0· 625), and VAS (r1=0· 703; r2=0· 682) scores in AR patients. Conclusion: The ECP-MPO test paper can effectively detect ECP in nasal secretions, and its results are consistent with those from the SPT, Der p-IgE and Der f-IgE result. Its chromogenic grade can reflect the symptom severity and specific cytokine and chemokine levels in AR patients.Keywords
This publication has 44 references indexed in Scilit:
- Dissecting the role of eosinophil cationic protein in upper airway diseaseCurrent Opinion in Allergy and Clinical Immunology, 2012
- Factors that affect the allergic rhinitis response to ragweed allergen exposureAnnals of Allergy, Asthma & Immunology, 2010
- Eosinophils and Th2 immunity: contemporary insightsImmunology & Cell Biology, 2010
- Histamine H1-receptor antagonists with immunomodulating activities: potential use for modulating T helper type 1 (Th1)/Th2 cytokine imbalance and inflammatory responses in allergic diseasesClinical and Experimental Immunology, 2009
- Nasal Eosinophils Display the Best Correlation with Symptoms, Pulmonary Function and Inflammation in Allergic RhinitisInternational Archives of Allergy and Immunology, 2005
- Relationship between nasal hyperreactivity, mediators and eosinophils in patients with perennial allergic rhinitis and controlsClinical & Experimental Allergy, 1996
- Measurement of serum levels of eosinophil cationic protein to monitor patients with seasonal respiratory allergy induced by Parietaria pollen (treated and untreated with specific immunotherapy)Allergy, 1996
- Eosinophil inflammation of the nasal mucosa in allergic and non‐allergic rhinitis measured by eosinophil cationic protein levels in native nasal fluid and serumClinical & Experimental Allergy, 1994
- Influence of Kupffer cell phagocytosis blockade on the production of ovalbumin‐specific IgE and IgG1 antibodies in an experimental modelClinical & Experimental Allergy, 1993
- Eosinophil cationic protein and myeloperoxidase in nasal secretion as markers of inflammation in allergic rhinitisAllergy, 1987